A Novel SCN9A Mutation (F826Y) in Primary Erythromelalgia Alters the Excitability of Nav1.7
- PMID: 28990532
- DOI: 10.2174/1566524017666171009105029
A Novel SCN9A Mutation (F826Y) in Primary Erythromelalgia Alters the Excitability of Nav1.7
Abstract
Background: Primary erythromelalgia (PE) is a dominant inherited disorder characterized by recurrent pain, redness, and warmth of the extremities that is caused by gain-of-function mutations in Nav1.7 encoding gene SCN9A. Most of the PE-causing mutations of Nav1.7 have been shown to be able to render Nav1.7-expressing cells hyperexcitable, however in most PE cases the symptoms are refractory to treatment with sodium channel blockers and the mechanism underlying the intractability has not been clearly clarified.
Objective: To identify the mutation of SCN9A in a Chinese Han family with typical symptoms of PE and study the electrophysiological effect of the identified mutation.
Methods: A Chinese Han family with typical symptoms of PE was collected and the proband's response to treatment was recorded. All the exons and flanking intronic sequences of SCN9A were amplified with PCR and sequenced. Several online programs were used to predict the damaging effect of variants. The functional effect of variants was studied by voltage-clamp analysis in CHO-K1 cells.
Results: The PE symptoms of the proband are refractory to all kinds of reported medications. Sequence analysis of SCN9A showed that a novel c.2477T>A (p. F826Y) mutation co-segregated with the disease phenotype. Several online programs predicted that the F826Y mutation has a deleterious effect on the gene product. Voltage-clamp analysis showed that while compared with the wild-type channel, activation of the F826Y mutant channel was shifted by 7.7 mV in a hyperpolarizing direction, whereas steadystate inactivation was shifted by 4.3 mV in a depolarizing direction.
Conclusion: A novel disease-causing SCN9A Mutation (F826Y) was identified in a Chinese family with typical PE symptoms refractory to treatment. F826Y of Nav1.7 could render DRG neurons hyperexcitable, contributing to the pathogenesis of PE.
Keywords: Nav1.7; Primary erythromelalgia; SCN9A; novel mutation; voltage-gated sodium channel; voltageclamp..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.
Similar articles
-
Nav1.7-A1632G Mutation from a Family with Inherited Erythromelalgia: Enhanced Firing of Dorsal Root Ganglia Neurons Evoked by Thermal Stimuli.J Neurosci. 2016 Jul 13;36(28):7511-22. doi: 10.1523/JNEUROSCI.0462-16.2016. J Neurosci. 2016. PMID: 27413160 Free PMC article.
-
Novel SCN9A mutations underlying extreme pain phenotypes: unexpected electrophysiological and clinical phenotype correlations.J Neurosci. 2015 May 20;35(20):7674-81. doi: 10.1523/JNEUROSCI.3935-14.2015. J Neurosci. 2015. PMID: 25995458 Free PMC article.
-
A novel SCN9A mutation responsible for primary erythromelalgia and is resistant to the treatment of sodium channel blockers.PLoS One. 2013;8(1):e55212. doi: 10.1371/journal.pone.0055212. Epub 2013 Jan 31. PLoS One. 2013. PMID: 23383113 Free PMC article.
-
Primary erythromelalgia: a review.Orphanet J Rare Dis. 2015 Sep 30;10:127. doi: 10.1186/s13023-015-0347-1. Orphanet J Rare Dis. 2015. PMID: 26419464 Free PMC article. Review.
-
Pediatric Erythromelalgia and SCN9A Mutations: Systematic Review and Single-Center Case Series.J Pediatr. 2019 Mar;206:217-224.e9. doi: 10.1016/j.jpeds.2018.10.024. Epub 2018 Nov 9. J Pediatr. 2019. PMID: 30416015
Cited by
-
Engineering Gain-of-Function Analogues of the Spider Venom Peptide HNTX-I, A Potent Blocker of the hNaV1.7 Sodium Channel.Toxins (Basel). 2018 Sep 4;10(9):358. doi: 10.3390/toxins10090358. Toxins (Basel). 2018. PMID: 30181499 Free PMC article.
-
Painful and painless mutations of SCN9A and SCN11A voltage-gated sodium channels.Pflugers Arch. 2020 Jul;472(7):865-880. doi: 10.1007/s00424-020-02419-9. Epub 2020 Jun 29. Pflugers Arch. 2020. PMID: 32601768 Free PMC article. Review.
-
Hydropathicity-based prediction of pain-causing NaV1.7 variants.BMC Bioinformatics. 2021 Apr 23;22(1):212. doi: 10.1186/s12859-021-04119-2. BMC Bioinformatics. 2021. PMID: 33892629 Free PMC article.
-
Discovery of a Novel Nav1.7 Inhibitor From Cyriopagopus albostriatus Venom With Potent Analgesic Efficacy.Front Pharmacol. 2018 Oct 16;9:1158. doi: 10.3389/fphar.2018.01158. eCollection 2018. Front Pharmacol. 2018. PMID: 30386239 Free PMC article.
-
Engineering of highly potent and selective HNTX-III mutant against hNav1.7 sodium channel for treatment of pain.J Biol Chem. 2021 Jan-Jun;296:100326. doi: 10.1016/j.jbc.2021.100326. Epub 2021 Jan 23. J Biol Chem. 2021. PMID: 33493520 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources